A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

Clinical trial NCT06706076 · RECRUITING

Trial details

NCT number: NCT06706076
Sponsor: BlossomHill Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

NSCLC (Advanced Non-small Cell Lung Cancer)

Start date: 2025-01-09
Primary completion: 2029-01-31
Enrollment: 675

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.